UCSF

ZINC02522669

Substance Information

In ZINC since Heavy atoms Benign functionality
October 27th, 2004 25 Yes

CAS Numbers: 1443-54-5 , 437-38-7 , 990-73-8

Other Names:

1-Phenethyl-4-(N-phenylpropionamido)piperidine

1-phenethyl-4-(N-phenylpropionamido)piperidine; 1-phenethyl-4-N-propionylanilinopiperidine; FENTANYL; N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide; N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide; N-(1-phenethyl-4-piperidyl)propionanilide; N-(1

1-Phenethyl-4-N-propionylanilinopiperidine

2-hydroxypropane-1,2,3-tricarboxylic acid; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

211

437-38-7

5-22-08-00049 (Beilstein Handbook Reference)

80832-90-2

990-73-8 (citrate)

990-73-8; D01399; Fentanyl citrate (JP16/USP); Fentora (TN); Lazanda (TN); Oralet (TN)

AC1L1FQ2

Actiq

ACTIQ; C22H28N2O; DEA No. 9801; Duragesic; EINECS 213-588-0; FENTANYL; FENTANYL CITRATE; FENTANYL CITRATE AND DROPERIDOL; FENTANYL CITRATE PRESERVATIVE FREE; Fentanyl Citrate [USAN:JAN]; Fentanyl dihydrogen citrate; Fentaz; Fentora; INNOVAR; LS-124441; Le

BAN

BIDD:GT0555

BRN 0494484

CHEBI:119915

CHEBI:130072

CHEBI:310077; CHEBI:5012

CHEMBL596

CID3345

D00320

DAP000072

DB00813

Duragesic

Duragesic (TN)

Duragesic-100

Duragesic-12

Duragesic-25

Duragesic-50

Duragesic-75

Durogesic

EINECS 207-113-6

FDA

FDA); Fentanyl HCl (FDA)

Fentanest

Fentanil

Fentanil [DCIT]

Fentanila

Fentanila [INN-Spanish]

Fentanila [INN-Spanish];Fentanyl citrate;Fentanylum [INN-Latin]

fentanila; fentanyl; fentanylum

Fentanyl (BAN

Fentanyl (FDA

Fentanyl (JAN/USAN/INN)

Fentanyl Citrate

Fentanyl [INN:BAN]

Fentanyl-100

Fentanyl-12

Fentanyl-25

Fentanyl-50

Fentanyl-75

Fentanylum

Fentanylum [INN-Latin]

Fentora

HSDB 3329

INN

INN); Fentanyl Citrate (JAN

IONSYS

JAN

JNS020QD

L001275

Leptanal

LS-124439

Matrifen

MCN-JR-4263-49

MCN-JR-4263-49; R-4263

MFCD00058359

MFCD00661055

MolPort-003-847-369

N- propionanilidehydrochloride

N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide

N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide

N-(1-phenethyl-4-piperidinyl)propionanilide dihydrogen citrate; N-(1-phenethyl-4-piperidyl)propionanilide citrate; N-(1-phenethyl-4-piperidyl)propionanilide dihydrogen citrate; N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide citrate; N-phenyl-N-[1-(2-p

N-(1-Phenethyl-4-piperidyl)propionanilide

N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide

N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide

N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide

N-Phenethyl-4-(N-propionylanilino)piperidine

N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide

N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

Nasalfent

NCGC00168252-01

Oprea1_152073

Oprea1_207148

Oralet

PDSP1_000860

PDSP2_000846

Pentanyl

Phentanyl

Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-

Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)

Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-

Propionanilide, N-(1-phenethyl-4-piperidyl)-

R 4263

R-4263

Rapinyl

Sentonil

Sublimase

Sublimaze

Subsys

UNII-UF599785JZ

USAN

USAN); Fentanyl citrate (FDA

USAN); Fentanyl Hydrochloride (FDA); Fentanyl Citrate (FDA

USP

USP)

USP); Fentanyl HCl (FDA)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.79 12.9 -56.53 1 3 1 25 337.487 6

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 6.605 Bitter DB
ALOGPS_SOLUBILITY 2.40e-02 g/l DrugBank-approved
UniProt Database Links NDF1_RAT; OPRM_HUMAN ChEBI

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AOFA-1-E Monoamine Oxidase A (cluster #1 Of 8), Eukaryotic Eukaryotes 5462 0.29 Binding ≤ 10μM
AOFB-1-E Monoamine Oxidase B (cluster #1 Of 8), Eukaryotic Eukaryotes 5462 0.29 Binding ≤ 10μM
OPRD-1-E Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 679 0.35 Binding ≤ 10μM
OPRK-1-E Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic Eukaryotes 5893 0.29 Binding ≤ 10μM
OPRM-1-E Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 8 0.45 Binding ≤ 10μM
SGMR1-1-E Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic Eukaryotes 25 0.43 Binding ≤ 10μM
OPRD-1-E Delta Opioid Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 7 0.46 Functional ≤ 10μM
OPRM-1-E Mu Opioid Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 2 0.49 Functional ≤ 10μM
Z50512-1-O Cavia Porcellus (cluster #1 Of 7), Other Other 5 0.46 Functional ≤ 10μM
Z50594-4-O Mus Musculus (cluster #4 Of 9), Other Other 9 0.45 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
OPRD_HUMAN P41143 Delta Opioid Receptor, Human 187 0.38 Binding ≤ 1μM
OPRD_RAT P33533 Delta Opioid Receptor, Rat 1.14 0.50 Binding ≤ 1μM
OPRK_HUMAN P41145 Kappa Opioid Receptor, Human 196.5 0.38 Binding ≤ 1μM
OPRK_CAVPO P41144 Kappa Opioid Receptor, Guinea Pig 298 0.37 Binding ≤ 1μM
OPRK_RAT P34975 Kappa Opioid Receptor, Rat 1.14 0.50 Binding ≤ 1μM
OPRM_HUMAN P35372 Mu Opioid Receptor, Human 1.3 0.50 Binding ≤ 1μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 1.14 0.50 Binding ≤ 1μM
SGMR1_RAT Q9R0C9 Sigma Opioid Receptor, Rat 1.14 0.50 Binding ≤ 1μM
OPRD_HUMAN P41143 Delta Opioid Receptor, Human 1035 0.34 Binding ≤ 10μM
OPRD_RAT P33533 Delta Opioid Receptor, Rat 1.14 0.50 Binding ≤ 10μM
OPRK_HUMAN P41145 Kappa Opioid Receptor, Human 1130 0.33 Binding ≤ 10μM
OPRK_CAVPO P41144 Kappa Opioid Receptor, Guinea Pig 298 0.37 Binding ≤ 10μM
OPRK_RAT P34975 Kappa Opioid Receptor, Rat 1.14 0.50 Binding ≤ 10μM
AOFA_HUMAN P21397 Monoamine Oxidase A, Human 5462 0.29 Binding ≤ 10μM
AOFB_HUMAN P27338 Monoamine Oxidase B, Human 5462 0.29 Binding ≤ 10μM
OPRM_HUMAN P35372 Mu Opioid Receptor, Human 1.3 0.50 Binding ≤ 10μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 1.14 0.50 Binding ≤ 10μM
SGMR1_RAT Q9R0C9 Sigma Opioid Receptor, Rat 1.14 0.50 Binding ≤ 10μM
Z50512 Z50512 Cavia Porcellus 1.76 0.49 Functional ≤ 10μM
OPRD_MOUSE P32300 Delta Opioid Receptor, Mouse 9.45 0.45 Functional ≤ 10μM
OPRM_CAVPO P97266 Mu Opioid Receptor, Guinea Pig 3.45 0.47 Functional ≤ 10μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 32.4 0.42 Functional ≤ 10μM
Z50594 Z50594 Mus Musculus 490 0.35 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Enzymatic degradation of dopamine by COMT
Enzymatic degradation of Dopamine by monoamine oxidase
G alpha (i) signalling events
G-protein activation
Metabolism of serotonin
Monoamines are oxidized to aldehydes by MAOA and MAOB, producing NH3 and H2O2
Norepinephrine Neurotransmitter Release Cycle
Opioid Signalling
Peptide ligand-binding receptors

Analogs ( Draw Identity 99% 90% 80% 70% )